Autor: |
Jesuthasan, Aaron, Baheerathan, Aravindhan, Auger, Stephen, Dorsey, Rachel, Coker, Robina, Selvapatt, Nowlan, Viegas, Stuart |
Předmět: |
|
Zdroj: |
Practical Neurology; Oct2024, Vol. 24 Issue 5, p1-9, 9p |
Abstrakt: |
The use of methotrexate in clinical practice has expanded significantly in recent years, as an effective chemotherapeutic agent as well as disease- modifying treatment for conditions such as rheumatoid arthritis, psoriasis and Crohn's disease. It is also used as a steroid- sparing agent for a range of inflammatory diseases of the central and peripheral nervous systems. Clinical neurologists must, therefore, know how to start and uptitrate methotrexate, its monitoring requirements and its potential toxicities. This review aims first to explore the evidence base for using methotrexate in various neurological diseases and second to discuss important practicalities around its use, ensuring its safe application and appropriate monitoring. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|